Phase Genomics Secures $1.5M Gates Foundation Grant to Combat Methane from Cattle and Drug-Resistant Bacteria
Seattle biotech startup Phase Genomics received a $1.5 million grant from the Bill & Melinda Gates Foundation to research bacteriophage-based treatments targeting drug-resistant bacteria and methane-producing microbes in cows. The project aims to reduce methane emissions from cattle, a leading agricultural greenhouse gas source.
Phase Genomics Secures $2.5M to Develop AI Platform for Detecting Cancer Chromosomal Aberrations
Seattle startup Phase Genomics received $2.5 million in funding, including $2 million from the U.S. National Cancer Institute and $500,000 from Washington state's Andy Hill CARE Fund, to advance its AI-driven platform that detects chromosomal aberrations in cancer. The funding supports projects analyzing tumor samples to develop predictive scores for cancers like acute myeloid leukemia and colorectal cancer.
AI, startups, and Star Wars: Highlights from the GeekWire Awards
The theme at this week's GeekWire Awards was Star Wars, but we didn't need to go to a galaxy far, far away to find the force that promises to reshape the technology industry. The game-changing potential of AI was on the minds of many finalists and attendees, and integral to the business models of many of the companies featured on stage. This episode features conversations with finalists and attendees about the economy, artificial intelligence, and more ... plus lots of cool tech along the way. GeekWire Awards 2023 revealed: Community honors top innovation in Pacific Northwest tech Seattle Seahawks legend…
Organizations
-
Phase Genomics Executive Officer, Director, Promoter 2017–present, Founder & CEO · current
Online
Questions about Ivan Liachko
Who is Ivan Liachko?
Ivan Liachko is the founder and CEO of Phase Genomics.
What is Ivan Liachko known for?
Ivan Liachko is known for work at Phase Genomics involving an AI platform for detecting cancer chromosomal aberrations and efforts to combat methane from cattle and drug-resistant bacteria.
What has Ivan Liachko been in the news for?
GeekWire reported in March 2024 on Phase Genomics’ efforts to combat methane from cattle and drug-resistant bacteria. GeekWire reported in August 2023 on Phase Genomics’ development of an AI platform for detecting cancer chromosomal aberrations.
Which organizations is Ivan Liachko associated with?
Ivan Liachko is associated with Phase Genomics as founder and CEO, with executive officer and promoter roles listed from 2017 to present.
Where is Ivan Liachko based?
Ivan Liachko is based in Seattle.